Single-nucleotide polymorphisms in chromosome 3p14.1- 3p14.2 are associated with susceptibility of Type 2 diabetes with cataract

Molecular Vision

Volumn 16, Issue , 2010, Pages 1206-1214

  Lin, Hui Ju ^a,b   Huang, Yu Chuen ^a,b   Lin, Jane Ming ^a,b   Wu, Jer Yuarn ^c   Chen, Liuh An ^a   Lin, Chao Jen ^d   Tsui, Yung Ping ^a,b   Chen, Chih Ping ^e   Tsai, Fuu Jen ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ADENYLYL CYCLASE ASSOCIATED PROTEIN; MYOSIN LIGHT CHAIN KINASE; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ALLELE; ARTICLE; CATARACT; CHINESE; CHROMOSOME 3P; CONTROLLED STUDY; GENE FUNCTION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MYOPIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ADULT; AGED; CASE-CONTROL STUDIES; CATARACT; CHROMOSOMES, HUMAN, PAIR 3; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MYOPIA; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77955593628     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Falck A, Laatikainen L. Diabetic cataract in children. Acta Ophthalmol Scand 1998; 76:238-40. [PMID: 9591961]
2. Bron AJ, Cheng H. Cataract and retinopathy: screening for treatable retinopathy. Clin Endocrinol Metab 1986; 15:971-99.
3. Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 1995; 119:295-300.
4. Di Benedetto A, Aragona P, Romano G, Romeo G, Di Cesare E, Spinella R, Ferreri G, Cucinotta D. Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients. J Diabetes Complications 1999; 13:159-62.
5. Dua HS, Said DG, Otri AM. Are we doing too many cataract operations? Cataract surgery: a global perspective. Br J Ophthalmol 2009; 93:1-2.
6. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414:782-7.
7. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365:1333-46.
8. Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, Andersen G, Ng DP, Holmkvist J, Borch-Johnsen K, Jørgensen T, Sandbaek A, Lauritzen T, Hansen T, Nurbaya S, Tsunoda T, Kubo M, Babazono T, Hirose H, Hayashi M, Iwamoto Y, Kashiwagi A, Kaku K, Kawamori R, Tai ES, Pedersen O, Kamatani N, Kadowaki T, Kikkawa R, Nakamura Y, Maeda S. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008; 40:1098-102.
9. Liu Y, Zhou DZ, Zhang D, Chen Z, Zhao T, Zhang Z, Ning M, Hu X, Yang YF, Zhang ZF, Yu L, He L, Xu H. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland China. Diabetologia 2009; 52:1315-21.
10. McDonough CW, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African- Americans. Hum Genet 2009; 126:265-75.
11. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993; 111:831-6.
12. Hall AB, Thompson JR, Deane JS, Rosenthal AR. LOCS III versus the Oxford clinical cataract classification and grading system for the assessment of nuclear, cortical and posterior subcapsular cataract. Ophthalmic Epidemiol 1997; 4:179-94.
13. Pan WH, Fann CS, Wu JY, Hung YT, Ho MS, Tai TH, Chen YJ, Liao CJ, Yang ML, Cheng AT, Chen YT. Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered 2006; 61:27-30.
14. Camargos S, Scholz S, Simón-Sánchez J, Paisán-Ruiz C, Lewis P, Hernandez D, Ding J, Gibbs JR, Cookson MR, Bras J, Guerreiro R, Oliveira CR, Lees A, Hardy J, Cardoso F, Singleton AB. DYT16, a novel young-onset dystoniaparkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol 2008; 7:207-15.
15. Duncan AJ, Bitner-Glindzicz M, Meunier B, Costello H, Hargreaves IP, López LC, Hirano M, Quinzii CM, Sadowski MI, Hardy J, Singleton A, Clayton PT, Rahman S. A nonsense mutation in COQ9 causes autosomal-recessive neonatalonset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet 2009; 84:558-66.
16. Dunning MJ, Barbosa-Morais NL, Lynch AG, Tavaré S, Ritchie ME. Statistical issues in the analysis of Illumina data. BMC Bioinformatics 2008; 9:85.
17. Ban HJ, Heo JY, Oh KS, Park KJ. Identification of Type 2 diabetes-associated combination of SNPs using Support Vector Machine. BMC Genet 2010; 11:26.
18. Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, Ohnaka K, Ikegami H, Sugiyama T, Katsuya T, Miyagishi M, Nakashima N, Nawata H, Nakamura J, Kono S, Takayanagi R, Kato N. Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009; 58:1690-9.
19. Zhao J, Bradfield JP, Zhang H, Annaiah K, Wang K, Kim CE, Glessner JT, Frackelton EC, Otieno FG, Doran J, Thomas KA, Garris M, Hou C, Chiavacci RM, Li M, Berkowitz RI, Hakonarson H, Grant SF. Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI. Diabetes 2010; 59:751-5.
20. Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JP. The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 2010; 171:645-55.
21. Liu C, Wu Y, Li H, Qi Q, Langenberg C, Loos RJ, Lin X. MTNR1B rs10830963 is associated with fasting plasma glucose, HbA1C and impaired beta-cell function in Chinese Hans from Shanghai. BMC Med Genet 2010; 11:59.
22. Stancáková A, Kuulasmaa T, Paananen J, Jackson AU, Bonnycastle LL, Collins FS, Boehnke M, Kuusisto J, Laakso M. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes 2009; 58:2129-36.
23. Chauhan G, Spurgeon CJ, Tabassum R, Bhaskar S, Kulkarni SR, Mahajan A, Chavali S, Kumar MV, Prakash S, Dwivedi OP, Ghosh S, Yajnik CS, Tandon N, Bharadwaj D, Chandak GR. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2 and CDKAL1 on the risk of type 2 diabetes in 5164 Indians. Diabetes. 2010
24. Jing YL, Sun QM, Bi Y, Shen SM, Zhu DL. SLC30A8 polymorphism and type 2 diabetes risk: Evidence from 27 study groups. Nutr Metab Cardiovasc Dis. 2010
25. Simonis-Bik AM, Nijpels G, van Haeften TW, Houwing-Duistermaat JJ, Boomsma DI, Reiling E, van Hove EC, Diamant M, Kramer MH, Heine RJ, Maassen JA, Slagboom PE, Willemsen G, Dekker JM, Eekhoff EM, de Geus EJ, 't Hart LM. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 2010; 59:293-301.
26. Boesgaard TW, Gjesing AP, Grarup N, Rutanen J, Jansson PA, Hribal ML, Sesti G, Fritsche A, Stefan N, Staiger H, Häring H, Smith U, Laakso M, Pedersen O, Hansen T. EUGENE2 Consortium. Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients--EUGENE2 study. PLoS One 2009; 4:e7236.
27. Fawcett KA, Wheeler E, Morris AP, Ricketts SL, Hallmans G, Rolandsson O, Daly A, Wasson J, Permutt A, Hattersley AT, Glaser B, Franks PW, McCarthy MI, Wareham NJ, Sandhu MS, Barroso I. Detailed investigation of the role of common and low-frequency WFS1 variants in type 2 diabetes risk. Diabetes 2010; 59:741-6.
28. Liu Y, Liu Z, Song Y, Zhou D, Zhang D, Zhao T, Chen Z, Yu L, Yang Y, Feng G, Li J, Zhang J, Liu S, Zhang Z, He L, Xu H. Meta-analysis Added Power to Identify Variants in FTO Associated With Type 2 Diabetes and Obesity in the Asian Population. Obesity (Silver Spring). 2010
29. Omori S, Tanaka Y, Horikoshi M, Takahashi A, Hara K, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Kadowaki T, Nakamura Y, Maeda S. Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals. Diabetologia 2009; 52:1554-60.
30. Grarup N, Andersen G, Krarup NT, Albrechtsen A, Schmitz O, Jørgensen T, Borch-Johnsen K, Hansen T, Pedersen O. Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes 2008; 57:2534-40.
31. McCarthy MI. Casting a wider net for diabetes susceptibility genes. Nat Genet 2008; 40:1039-40.
32. The international HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449:851-61.
33. Yan L, Figueroa DJ, Austin CP, Liu Y, Bugianesi RM, Slaughter RS, Kaczorowski GJ, Kohler MG. Expression of voltage-gated potassium channels in human and rhesus pancreatic islets. Diabetes 2004; 53:597-607.
34. Grover GJ, Mellström K, Malm J. Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes. Curr Vasc Pharmacol 2007; 5:141-54.
35. Baxter JD, Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 2009; 8:308-20.
36. Crunkhorn S, Patti ME. Links between thyroid hormone action, oxidative metabolism, and diabetes risk? Thyroid 2008; 18:227-37.
37. Ribeiro MO. Effects of thyroid hormone analogs on lipid metabolism and thermogenesis. Thyroid 2008; 18:197-203.
38. Videla LA, Fernandez V, Tapia G, Varela P. Thyroid hormone calorigenesis and mitochondrial redox signaling: upregulation of gene expression. Front Biosci 2007; 12:1220-8.
39. Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 2004; 9:26-53.
40. Said G. Diabetic neuropathy. Nat Clin Pract Neurol 2007; 3:331-40.
41. Hernández-Pedro N, Ordóñez G, Ortiz-Plata A, Palencia-Hernández G, García-Ulloa AC, Flores-Estrada D, Sotelo J, Arrieta O. All-trans retinoic acid induces nerve regeneration and increases serum and nerve contents of neural growth factor in experimental diabetic neuropathy. Transl Res 2008; 152:31-7.
42. Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, Kang SW, Han DS, Han JY, Cha DR. Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol 2004; 82:568-76.
43. Yamakoshi Y, Fukasawa H, Yamauchi T, Waki H, Kadowaki T, Shudo K, Kagechi H. Determination of endogenous levels of retinoic acid isomers in type II diabetes mellitus patients. Possible correlation with HbA1c values. Biol Pharm Bull 2002; 25:1268-71.
44. Clements RT, Sodha NR, Feng J, Boodhwani M, Liu Y, Mieno S, Khabbaz KR, Bianchi C, Sellke FW. Impaired coronary microvascular dilation correlates with enhanced vascular smooth muscle MLC phosphorylation in diabetes. Microcirculation 2009; 16:193-206.
45. Monnier L, Colette C, Owens DR. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab Res Rev 2009; 25:393-402.
46. Zhu H, Zhang X, Zuo L, Zhou Q, Gui S, Wei W, Wang Y. Expression of Myosin Light Chain Kinase in Kidney of Streptozotocin-Induced Diabetic Rats. Int J Mol Sci 2006; 7:510-51.
47. Liu X, Takeda N, Dhalla NS. Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats. Metabolism 1997; 46:71-5.
48. Hashim S, Li Y, Nagakura A, Takeo S, Anand-Srivastava MB. Modulation of G-protein expression and adenylyl cyclase signaling by high glucose in vascular smooth muscle. Cardiovasc Res 2004; 63:709-18.
49. Shpakov AO, Kuznetsova LA, Plesneva SA, Bondareva VM, Guryanov IA, Vlasov GP, Pertseva MN. Decrease in functional activity of G-proteins hormone-sensitive adenylate cyclase signaling system, during experimental type II diabetes mellitus. Bull Exp Biol Med 2006; 142:685-9.
50. Long SB, Tao X, Campbell EB, MacKinnon R. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature 2007; 450:376-82.
51. Jensen MØ, Borhani DW, Lindorff-Larsen K, Maragakis P, Jogini V, Eastwood MP, Dror RO, Shaw DE. Principles of conduction and hydrophobic gating in K+ channels. Proc Natl Acad Sci USA 2010; 107:5833-8.
52. Gredilla R, Barja G, López-Torres M. Thyroid hormoneinduced oxidative damage on lipids, glutathione and DNA in the mouse heart. Free Radic Biol Med 2001; 35:417-25.
53. Guerrero A, Pamplona R, Portero-Otin M, Barja G, López-Torres M. Effect of thyroid status on lipid composition and peroxidation in the mouse liver. Free Radic Biol Med 1999; 261:73-80.
54. Das K, Chainey GB. Modulation of rat liver mitochondrial antioxidant defence system by thyroid hormone. Biochim Biophys Acta 2001; 1537:1-13.
55. Nishikiori N, Osanai M, Chiba H, Kojima T, Ohguro H, Sawada N. Inhibitory effects of retinoic acid receptor alpha stimulants on murine cataractogenesis through suppression of deregulated calpains. Invest Ophthalmol Vis Sci 2007; 48:2224-9.
56. Harper JM, Wolf N, Galecki AT, Pinkosky SL, Miller RA. Hormone levels and cataract scores as sex-specific, mid-life predictors of longevity in genetically heterogeneous mice. Mech Ageing Dev 2003; 124:801-10.
57. Cauwe B, Martens E, Van den Steen PE, Proost P, Van Aelst I, Blockmans D, Opdenakker G. Adenylyl cyclase-associated protein-1/CAP1 as a biological target substrate of gelatinase B/MMP-9. Exp Cell Res 2008; 314:2739-49.